<DOC>
	<DOCNO>NCT01906814</DOCNO>
	<brief_summary>The purpose study determine whether 3 cycle chemotherapy ( CEV ) effective 6 cycle chemotherapy ( CEV ) treatment Stage I enucleate retinoblastoma .</brief_summary>
	<brief_title>Adjuvant Chemotherapy High-risk Retinoblastoma After Enucleation</brief_title>
	<detailed_description>This study phase â…¢ open label interventional case series . Patients Stage I enucleate retinoblastoma randomize receive chemotherapy ( CEV ) 3 cycle 6 cycle monthly basis . Patients follow 24 month .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Ability provide write informed consent comply study assessment full duration study . Definite pathology sign retinoblastoma , Stage I base International Retinoblastoma Staging System . Received enucleation study eye . Monocular retinoblastoma . Any previous disease study eye . Previous participation study investigational drug within 1 month precede Day 0 ( exclude vitamin mineral ) . History chemical intervention retinoblastoma study eye .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>